Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis
Status:
Not yet recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Many patients who undergo vascular surgery to improve the blood flow to their legs are at
risk of developing an infection in the surgical site and are then at risk of serious
complications such as hospital readmission, failure of the surgical procedure and lower limb
amputation. Surgical site infections may be reduced in high-risk patients by applying two
commonly used antibiotics (gentamicin and vancomycin) into the surgical incision at the end
of the surgical procedure. This will be compared to the standard of care treatment at London
Health Sciences Center.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Lawson Health Research Institute
Treatments:
Anti-Infective Agents Anti-Infective Agents, Local Gentamicins Vancomycin